Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]

Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original artic...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2017
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/b04edf6e052e42608bde9d4d6babb983
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:b04edf6e052e42608bde9d4d6babb983
record_format	dspace
spelling	oai:doaj.org-article:b04edf6e052e42608bde9d4d6babb9832021-12-02T05:13:45ZWorsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]1177-5483https://doaj.org/article/b04edf6e052e42608bde9d4d6babb9832017-02-01T00:00:00Zhttps://www.dovepress.com/corrigendum-worsening-anatomic-outcomes-following-aflibercept-for-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original article.Nudleman EWolfe JDWoodward MAYonekawa YWilliams GAHassan TSDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 355-356 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Nudleman E Wolfe JD Woodward MA Yonekawa Y Williams GA Hassan TS Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
description	Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original article.
format	article
author	Nudleman E Wolfe JD Woodward MA Yonekawa Y Williams GA Hassan TS
author_facet	Nudleman E Wolfe JD Woodward MA Yonekawa Y Williams GA Hassan TS
author_sort	Nudleman E
title	Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_short	Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_full	Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_fullStr	Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_full_unstemmed	Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_sort	worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [corrigendum]
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/b04edf6e052e42608bde9d4d6babb983
work_keys_str_mv	AT nudlemane worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT wolfejd worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT woodwardma worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT yonekaway worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT williamsga worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT hassants worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum
_version_	1718400493398523904

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]

Documents similaires